期刊文献+

阿昔洛韦血浆浓度的自动柱切换高效液相色谱法测定 被引量:4

Determination of acyclovir in human plasma by automated column-switching HPLC
下载PDF
导出
摘要 目的 :建立适应大批量样品快速自动分析的阿昔洛韦血药浓度HPLC测定方法。方法 :应用自制自动磁力定时切换装置。分析柱采用WatersNova PakC18柱 (15 0mm× 3.9mm ,4μm) ,分析流动相为甲醇 - 0 .0 1mol·L-1磷酸氢二钾缓冲液 =3∶97(v/v) ,流速 1ml·min-1;预处理柱为 μBondapakC18柱 (5 0mm× 4.6mm ,37~ 5 0 μm) ,预处理流动相 (PMP)为含0 .0 1mol·L-1庚烷磺酸钠的磷酸缓冲液 ,流速 1ml·min-1;检测波长 2 5 4nm。结果 :阿昔洛韦血药浓度在 40~ 12 80ng·ml-1线性良好(r =0 .9998) ,最低检测限约为 2ng(S/N≥ 3) ,最低血浆药物检测浓度为 8ng·ml-1;绝对和相对回收率分别为 (91.2± 8.3) %和 (98.3± 5 .5 ) % ;日内及日间精密度都小于 10 %。结论 :方法简便、快速、灵敏、准确 ,适于大批量血样的分析。 OBJECTIVE:To establish an automated HPLC method for determination of acyclovir in human plasma.METHODS:A self-made automated column-switching control system was used.The analytical column (150 mm× 3.9 mm) was packed with μ Waters Nova-pak C 18 (4 μm) and the pre-column (50 mm× 4.6 mm) was packed with μ Bondapak C 18 (37~50 μm).Methanol-0.01 mol·L -1 dipotassium hydrogen phosphate (3∶97,v/v) was used as analytical mobile-phase and a phosphate buffer with 0.01 mol·L -1 sodium heptane sulfonate was used as pre-mobile-phase.The determination wavelength was 254 nm.RESULTS:The concentration of acyclovir in human plasma was linear with the area of chromatographic peak in 40~1280 ng·ml -1 ,the determination limit was 10 ng·ml -1 .The absolute and relative recoveries were ( 91.2 ± 8.3 )% and ( 98.3 ± 5.5 )%,respectively.The RSD were less than 10%.CONCLUSIONS:The method is simple,rapid,sensitive and accurate,which can apply to analysis of plenty of plasma samples.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2000年第8期453-456,共4页 Chinese Journal of Hospital Pharmacy
基金 全军"八五"规划科研基金!资助项目 编号 91D0 6 2 -0 313
关键词 阿昔洛韦 高效液相色谱法 自动柱切换 血药浓度 acyclovir plasma drug concentration HPLC automated column-switching
  • 相关文献

参考文献1

共引文献8

同被引文献25

  • 1吴刚,孙长海,任淑清.人体内阿昔洛韦血药浓度的HPLC测定[J].黑龙江医药科学,2005,28(2):42-43. 被引量:2
  • 2刘韬,王建华.离子对高效液相色谱法测定人体血浆中阿昔洛韦的浓度[J].中国药房,1997,8(3):118-119. 被引量:10
  • 3潘卫三,刘宏飞,刘阳.阿昔洛韦药物树脂生物粘附缓释液体制剂及其制备方法:中国,200310105138.X[P].2005-05-25.
  • 4.中国药典[S]:2000版:二部[M].,.332-333.
  • 5Quinn RP, Miranda PD. A sensitive radioimmunoassay for the antiviral agent BW248U[J]. Anal Biochem ,1979,98:319-328.
  • 6Tadepalli SM, Quinn RP, Averett DR. A competitive enzyme - linked immunosorbent assay to quantitate acyclovir and BW B759U in human plasma and urine[J]. Antimicro Agent Chemother , 1986,29:93-98.
  • 7Bangaru RA, Bansal YK, Rao ARM ,et al. Rapid, simple and sensitive high -performance liquid chromatographic method for detection and determination acyclovir in human plasma and its use in bioavailability studies[J]. J Chromatogr B, 2000,739:231-237.
  • 8Cociglio M, Peyriere H, Hillaire-Buys D. Application of a standardized coextractive cleanup procedure to routine high - performance liquid chromatography assays of teicoplanin and ganciclovir in plasma [ J ]. J Chromatogr B, 1998,705:79-85.
  • 9Page T, Sherwood C, Connor JD,et al. Simple reversed - phase high-performance liquid chromatography quantitation of ganciclovir in human serum and urine[J]. J Chromatogr B, 1996,675:342-346.
  • 10Svensson JO, Barkhoh L, Sawe J9- Determination of acyclovir and its metabolite in serum and urine using solid - phase extraction and high-performance liquid chromatography [ J ]. J Chromatogr B1997,690:363-366.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部